Coronavirus: The world is looking towards India for the vaccine, know the reason

Posted on 27th Apr 2020 by rohit kumar

new Delhi. Coronavirus has killed more than 2 lakh people so far. About 3 million people are infected with the Covid-19 virus. All the countries of the world are engaged in making vaccines or medicines to get rid of this virus, but so far no one has been successful. In such a situation, now the world is looking towards India in the hope of Covid-19 vaccine.

 

About two weeks ago, US Secretary of State Mike Pompeo said that India and the United States are developing a coronavirus vaccine to get rid of the corona virus. Pompeo was not saying such a thing, which should surprise. Actually, these two countries have been working together for three decades to make vaccines. Both countries are running joint vaccine development programs. India and the United States have worked together to prevent dengue, bowel disease, influenza and TB. Now work is being done on dengue vaccine trial in the near future.

 

India is the largest manufacturer of generic medicines and vaccines in the world. It is a country of half a dozen major vaccine manufacturers. Here polio, meningitis, pneumonia, rotavirus, BCG, measles, mumps and rubella vaccines or pharmaceutical supplements are made. Now half a dozen Indian companies are developing vaccines to stop Covid-19.

 

According to the BBC, such companies include the Serum Institute of India. It is the world's largest manufacturer of vaccines and its doses. The 53-year-old company produces 1.5 billion doses every year. About 7,000 people work in this company. The company supplies 20 vaccines in 165 countries. Now the firm has tied up with American biotech company Kodagenics to develop a live attenuated vaccine.

 

 

 

Adar Poonawala, CEO of Serum Institute of India, said, "We are planning a trial on this vaccine mice in April. We will be in a position to conduct trials on humans by September. ”The Serum Institute of India has also tied up for the production of the vaccine developed by Oxford University. Its human trial will start in Oxford from Thursday. Prof. Adrian Hill, who runs the Jenner Institute in Oxford, said, "The world needs millions of doses by the end of the year." The Indian firm has the additional capacity to produce 400 to 500 million doses. '

 

Hyderabad-based Bharat Biotech has tied up with the University of Wisconsin-Madison and US-based firm Flujon to manufacture around 300 million doses of the vaccine. Zydus Cadila is working on two vaccines. Biological E, Indian Immunologicals and Minwax are also involved in developing the vaccine. Four-five more firms are also trying to develop the vaccine.

 

World Health Organization (WHO) Chief Scientist Soumya Swaminathan said, "The credit should go to the entrepreneurs and pharmaceutical companies who have invested in quality manufacturing." The owners of these companies have set a target of business along with doing good work, which is good for the world. '

 

However, experts warn that people should not expect the vaccine to come too soon. David Nabarro, professor of global health at Imperial College, London, says humans will have to live with the threat of the corono virus in the near future. There is no guarantee that a vaccine will be successfully developed quickly.